Zhuan Zhou

Zhuan Zhou

Auto-generated profile, based on publicly available information

Zhuan Zhou

Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Cell Division
Verified
Journal Article
Open access
PDF file
ZZZhuan Zhou
Zhuan Zhou
MHMingjing He
Mingjing He
ASAnil A. Shah
Anil A. Shah
YWYong Wan
Yong Wan
Anaphase-promoting complex/cyclosome (APC/C) is a multifunctional ubiquitin-protein ligase that targets different substrates for ubiquitylation and therefore regulates a variety of cellular processes such as cell division, differentiation, genome stability, energy metabolism, cell death, autophagy as well as carcinogenesis. Activity of APC/C is principally governed by two WD-40 domain proteins, Cdc20 and Cdh1, in and beyond cell cycle. In the past decade, the results based on numerous biochemical, 3D structural, mouse genetic and small molecule inhibitor studies have largely attracted our attention into the emerging role of APC/C and its regulation in biological function, human diseases and potential therapeutics. This review will aim to summarize some recently reported insights into APC/C in regulating cellular function, connection of its dysfunction with human diseases and its implication of therapeutics.

1 September 2017 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
MHMingjing He
Mingjing He
ZZZhuan Zhou
Zhuan Zhou
GWGeorge Wu
George Wu
QCQianming Chen
Qianming Chen
YWYong Wan
Yong Wan

20 December 2016 in Cell & Bioscience
Verified
Journal Article
Open access
PDF file
MHMingjing He
Mingjing He
ZZZhuan Zhou
Zhuan Zhou
ASAnil A. Shah
Anil A. Shah
HZHaojing Zou
Haojing Zou
JTJin Tao
Jin Tao
YWYong Wan
Yong Wan
The addition of mono-ubiquitin or poly-ubiquitin chain to signaling proteins in response to DNA damage signal is thought to be a critical event that facilitates the recognition of DNA damage lesion site, the activation of checkpoint function, termination and checkpoint response and the recruitment of DNA repair proteins. Despite the ubiquitin modifiers, removal of ubiquitin from the functional proteins by the deubiquitinating enzymes (DUBs) plays an important role in orchestrating DNA damage response as well as DNA repair processes. Deregulated ubiquitination and deubiquitination could lead to genome instability that in turn causes tumorigenesis. Recent TCGA study has further revealed the connection between mutations in alteration of DUBs and various types of tumors. In addition, emerging drug design based on DUBs provides a new avenue for anti-cancer therapy. In this review, we will summarize the role of deubiquitination and specificity of DUBs, and highlight the recent discoveries of DUBs in the modulation of ubiquitin-mediated DNA damage response and DNA damage repair. We will furthermore discuss the DUBs involved in the tumorigenesis as well as interception of deubiquitination as a novel strategy for anti-cancer therapy.

31 March 2016 in Cell Division
Verified
Journal Article
Open access
PDF file
MHMingjing He
Mingjing He
ZZZhuan Zhou
Zhuan Zhou
ASAnil A. Shah
Anil A. Shah
YHYang Hong
Yang Hong
QCQianming Chen
Qianming Chen
YWYong Wan
Yong Wan
PTMs (posttranslational modifications) such as ubiquitylation, sumoylation, acetylation and protein methylation are pivotal modifiers that determine the activation, deactivation or subcellular localization of signaling proteins, facilitating the initiation, amplification and transduction of signaling. Accumulating evidence suggest that several key signaling molecules in Hippo signaling pathway are tightly regulated by various types of PTMs. Malfunction of these critical signaling modules such as YAP/TAZ, MAT1/2 and LATS1/2 due to deregulated PTMs has been linked to a variety of human diseases such as cancer. In this review article, we summarized the current understanding of the impact of PTMs in regulating Hippo signaling pathway and further discussed the potential therapeutic intervention from the view of PTMs and Hippo pathway.